Viewing Study NCT01090466


Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2025-12-26 @ 10:20 PM
Study NCT ID: NCT01090466
Status: COMPLETED
Last Update Posted: 2018-02-06
First Post: 2010-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
Sponsor: Cardiff University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module